Dyronib - Dasatinib 50mg 60 Tablets (Sprycel) - Anticancer Medication

Dyronib (Dasatinib 50 mg) x 60 Tablets

$225.00 $110.00
image Prescription Required

Dyronib 50 mg Tablet is an oral anti-cancer medication containing Dasatinib, a tyrosine kinase inhibitor used in the treatment of Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) and acute lymphoblastic leukemia (Ph+ ALL).

Generic Name Dasatinib
Manufacturer Hetero Healthcare Limited
Packing 60 Tablets
Prescribed For Blood Cancer
Availability In Stock

Contact us on WhatsApp

Genuine Medicines

Quick Air Delivery

Secure Payment

24/7 Support

Benefits of Dyronib 50mg

  • Treats chronic myeloid leukemia (CML)
  • Blocks cancer cell growth
  • Targets specific cancer proteins
  • Supports long-term therapy

Side Effects

  • Nausea, vomiting, and diarrhea
  • Fatigue or weakness
  • Headache
  • Skin rash or itching
  • Muscle or joint pain
  • Swelling in hands, feet, or around the eyes (edema)
  • Loss of appetite

Caution:

  • Take exactly as prescribed.
  • Do not skip or stop doses without medical advice.
  • Inform your doctor of heart, lung, or liver problems.
  • Monitor blood counts and heart function regularly.
  • Avoid grapefruit or grapefruit juice.
  • Not a cure; continue regular check-ups.
  • Do not share medication.

Get Dyronib (Dasatinib 50 mg) Tablets in Bulk at Wholesale Prices from Our Generic Pharmacy

As a reliable supplier of generic anticancer medications, we provide Dyronib (Dasatinib 50 mg) Tablets, widely used for the treatment of Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL).

We ensure consistent, safe, and timely bulk supply of oncology drugs, including Dasatinib (Generic Sprycel), to hospitals, clinics, pharmacies, healthcare providers, physicians, NGOs, and authorized buyers in over 80 countries worldwide. Our distribution network spans Latin America, Africa, Asia, Europe, the Middle East, and North America, covering key markets such as Mexico, Brazil, Colombia, Peru, Chile, UAE, Saudi Arabia, Egypt, South Africa, Namibia, Kenya, Nigeria, Singapore, Vietnam, Thailand, the Philippines, Canada, and many more.

Disclaimer

This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.

Need assistance? Chat with us